ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/(R)-2-Amino-3-(6-bromo-1H-indol-3-yl)propanoic acid
C11H11BrN2O2
283.12 g/mol
Pharmaceutical Intermediate

(R)-2-Amino-3-(6-bromo-1H-indol-3-yl)propanoic acid

CAS496930-10-0
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a brominated derivative of D-tryptophan, commonly used as a peptide building block in research. Its structure includes an indole ring with a bromine substituent, which can influence the properties of synthetic peptides.

Peptide building block for research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing (R)-2-Amino-3-(6-bromo-1H-indol-3-yl)propanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

4-Amino-2,5-dimethoxy-N-methylbenzenesulphonamide

CAS49701-24-8

pharmaceutical intermediate

ReferenceSame Category

4-(4-Chlorophenyl)cyclohexanecarboxylic acid

CAS49708-81-8

pharmaceutical intermediate

ReferenceSame Category

4-Methyl-D-phenylalanine

CAS49759-61-7

pharmaceutical intermediate

ReferenceSame Category

Scopine

CAS498-45-3

pharmaceutical intermediate

Referencestereoisomer of

L-6'-bromotryptophan

CAS52448-17-6

research compound

Referencestereoisomer of

6-BROMO-DL-TRYPTOPHAN

CAS33599-61-0

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2R)-2-amino-3-(6-bromo-1H-indol-3-yl)propanoic acid

InChIKey

OAORYCZPERQARS-SECBINFHSA-N

SMILES

C1=CC2=C(C=C1Br)NC=C2C[C@H](C(=O)O)N

Synonyms (5)
  • 6-BROMO-D-TRYPTOPHAN
  • H-D-Trp(6-Br)-OH

Sourcing (R)-2-Amino-3-(6-bromo-1H-indol-3-yl)propanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→